CD177	B:C1824675
(+	O
)	O
neutrophils	O
as	O
functionally	O
activated	O
neutrophils	O
negatively	O
regulate	O
IBD	O
.	O

CD177	O
(+	O
)	O
neutrophils	B:C0027950
as	O
functionally	O
activated	O
neutrophils	O
negatively	O
regulate	O
IBD	O
.	O

CD177	O
(+	O
)	O
neutrophils	O
as	O
functionally	O
activated	O
neutrophils	B:C0027950
negatively	O
regulate	O
IBD	O
.	O

CD177	O
(+	O
)	O
neutrophils	O
as	O
functionally	O
activated	O
neutrophils	O
negatively	O
regulate	O
IBD	B:C0021390
.	O

Neutrophils	B:C0027950
are	O
accumulated	O
in	O
inflamed	O
mucosa	O
of	O
IBD	O
and	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
.	O

Neutrophils	O
are	O
accumulated	O
in	O
inflamed	O
mucosa	O
of	O
IBD	B:C0021390
and	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	O
.	O

Neutrophils	O
are	O
accumulated	O
in	O
inflamed	O
mucosa	O
of	O
IBD	O
and	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	B:C0699748
.	O

CD177	B:C1824675
is	O
expressed	O
in	O
neutrophils	O
specifically	O
and	O
upregulated	O
during	O
inflammation	O
.	O

CD177	O
is	O
expressed	B:C0017262
in	O
neutrophils	O
specifically	O
and	O
upregulated	O
during	O
inflammation	O
.	O

CD177	O
is	O
expressed	O
in	O
neutrophils	B:C0027950
specifically	O
and	O
upregulated	O
during	O
inflammation	O
.	O

CD177	O
is	O
expressed	O
in	O
neutrophils	O
specifically	O
and	O
upregulated	B:C0041904
during	O
inflammation	O
.	O

CD177	O
is	O
expressed	O
in	O
neutrophils	O
specifically	O
and	O
upregulated	O
during	O
inflammation	B:C0021368
.	O

However	O
,	O
the	O
role	O
of	O
CD177	B:C1824675
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
pathogenesis	O
of	O
IBD	O
remains	O
elusive	O
.	O

However	O
,	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	B:C0027950
in	O
pathogenesis	O
of	O
IBD	O
remains	O
elusive	O
.	O

However	O
,	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
pathogenesis	B:C0699748
of	O
IBD	O
remains	O
elusive	O
.	O

However	O
,	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
pathogenesis	O
of	O
IBD	B:C0021390
remains	O
elusive	O
.	O

Expression	B:C0017262
of	O
CD177	O
was	O
analysed	O
in	O
peripheral	O
blood	I:C0229664
and	O
intestinal	O
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	O
using	O
quantitative	O
RT	O
-	I:C0599161
PCR	I:C0599161
,	O
flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	O
.	O

Expression	O
of	O
CD177	B:C1824675
was	O
analysed	O
in	O
peripheral	O
blood	I:C0229664
and	O
intestinal	O
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	O
using	O
quantitative	O
RT	O
-	I:C0599161
PCR	I:C0599161
,	O
flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	O
.	O

Expression	O
of	O
CD177	O
was	O
analysed	O
in	O
peripheral	B:C0229664
blood	I:C0229664
and	O
intestinal	O
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	O
using	O
quantitative	O
RT	O
-	I:C0599161
PCR	I:C0599161
,	O
flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	O
.	O

Expression	O
of	O
CD177	O
was	O
analysed	O
in	O
peripheral	O
blood	I:C0229664
and	O
intestinal	B:C0021839
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	O
using	O
quantitative	O
RT	O
-	I:C0599161
PCR	I:C0599161
,	O
flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	O
.	O

Expression	O
of	O
CD177	O
was	O
analysed	O
in	O
peripheral	O
blood	I:C0229664
and	O
intestinal	O
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	B:C0021390
using	O
quantitative	O
RT	O
-	I:C0599161
PCR	I:C0599161
,	O
flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	O
.	O

Expression	O
of	O
CD177	O
was	O
analysed	O
in	O
peripheral	O
blood	I:C0229664
and	O
intestinal	O
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	O
using	O
quantitative	O
RT	B:C0599161
-	I:C0599161
PCR	I:C0599161
,	O
flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	O
.	O

Expression	O
of	O
CD177	O
was	O
analysed	O
in	O
peripheral	O
blood	I:C0229664
and	O
intestinal	O
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	O
using	O
quantitative	O
RT	O
-	I:C0599161
PCR	I:C0599161
,	O
flow	B:C0016263
cytometry	I:C0016263
and	O
immunohistochemistry	O
.	O

Expression	O
of	O
CD177	O
was	O
analysed	O
in	O
peripheral	O
blood	I:C0229664
and	O
intestinal	O
mucosa	I:C0021839
from	O
patients	O
with	O
IBD	O
using	O
quantitative	O
RT	O
-	I:C0599161
PCR	I:C0599161
,	O
flow	O
cytometry	I:C0016263
and	O
immunohistochemistry	B:C0021044
.	O

CD177	B:C1824675
(+)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
were	O
isolated	O
to	O
determine	O
gene	O
differences	O
by	O
RNA	O
sequencing	I:C0917793
.	O

CD177	O
(+)	I:C1824675
and	O
CD177	B:C1824675
(	I:C1824675
-)	I:C1824675
neutrophils	O
were	O
isolated	O
to	O
determine	O
gene	O
differences	O
by	O
RNA	O
sequencing	I:C0917793
.	O

CD177	O
(+)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	B:C0027950
were	O
isolated	O
to	O
determine	O
gene	O
differences	O
by	O
RNA	O
sequencing	I:C0917793
.	O

CD177	O
(+)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
were	O
isolated	O
to	O
determine	O
gene	B:C0017337
differences	O
by	O
RNA	O
sequencing	I:C0917793
.	O

CD177	O
(+)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
were	O
isolated	O
to	O
determine	O
gene	O
differences	O
by	O
RNA	B:C0917793
sequencing	I:C0917793
.	O

Colitis	B:C0009319
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	B:C1824675
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	B:C1520150
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	B:C0079225
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	B:C0079225
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	B:C1824675
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	B:C0027950
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	B:C0021390
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	B:C1824675
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	B:C0027950
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	B:C0229664
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	O
compared	O
with	O
healthy	O
controls	O
.	O

Colitis	O
was	O
established	O
in	O
CD177	O
(	I:C1824675
-/-)	I:C1824675
and	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
in	O
response	O
to	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
(	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
)	O
insults	O
to	O
determine	O
the	O
role	O
of	O
CD177	O
(+	I:C1824675
)	I:C1824675
neutrophils	O
in	O
IBD.	O
CD177	O
(+)	I:C1824675
neutrophils	O
were	O
markedly	O
increased	O
in	O
peripheral	O
blood	I:C0229664
and	O
inflamed	O
mucosa	O
from	O
patients	O
with	O
active	O
IBD	B:C0021390
compared	O
with	O
healthy	O
controls	O
.	O

RNA	B:C0917793
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	B:C0017262
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	B:C1824675
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	B:C1824675
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	B:C0027950
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	B:C0021390
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	B:C1327592
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	B:C0020281
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

RNA	O
sequencing	I:C0917793
revealed	O
that	O
differential	O
gene	O
expression	I:C0017262
between	O
CD177	O
(+	I:C1824675
)	I:C1824675
and	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
from	O
patients	O
with	O
IBD	O
was	O
associated	O
with	O
response	O
to	O
bacterial	O
defence	I:C1327592
,	O
hydrogen	O
peroxide	I:C0020281
and	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
(	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
)	O
.	O

CD177	B:C1824675
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	B:C0027950
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	B:C0079189
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	B:C0021745
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	B:C0021760
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	B:C1705947
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	B:C0961814
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	B:C0040690
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	B:C0544570
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	B:C0162772
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	B:C0030956
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	B:C3850088
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	O
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
produced	O
lower	O
levels	O
of	O
proinflammatory	O
cytokines	I:C0079189
(	O
ie	O
,	O
interferon	O
-γ	I:C0021745
,	O
interleukin	O
(	I:C0021760
IL	I:C0021760
)	I:C0021760
-	I:C0021760
6	I:C0021760
,	O
IL	O
-	I:C1705947
17A	I:C1705947
)	O
,	O
but	O
higher	O
levels	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
and	O
transforming	O
growth	I:C0040690
factor	I:C0040690
-β	I:C0040690
,	O
and	O
exhibited	O
increased	O
bactericidal	O
activities	I:C0544570
(	O
ie	O
,	O
reactive	O
oxygen	I:C0162772
species	I:C0162772
,	O
antimicrobial	O
peptides	I:C0030956
,	O
neutrophil	O
extracellular	I:C3850088
trap	I:C3850088
)	O
compared	O
with	O
CD177	B:C1824675
(	I:C1824675
-)	I:C1824675
subset	O
.	O

CD177	B:C1824675
(-/-)	I:C1824675
mice	O
developed	O
more	O
severe	O
colitis	O
on	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
insults	O
compared	O
with	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
.	O

CD177	O
(-/-)	I:C1824675
mice	B:C0026809
developed	O
more	O
severe	O
colitis	O
on	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
insults	O
compared	O
with	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
.	O

CD177	O
(-/-)	I:C1824675
mice	O
developed	O
more	O
severe	O
colitis	B:C0009319
on	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
insults	O
compared	O
with	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
.	O

CD177	O
(-/-)	I:C1824675
mice	O
developed	O
more	O
severe	O
colitis	O
on	O
dextran	B:C0079225
sulfate	I:C0079225
sodium	I:C0079225
insults	O
compared	O
with	O
wild	O
-	I:C1520150
type	I:C1520150
mice	I:C1520150
.	O

CD177	O
(-/-)	I:C1824675
mice	O
developed	O
more	O
severe	O
colitis	O
on	O
dextran	O
sulfate	I:C0079225
sodium	I:C0079225
insults	O
compared	O
with	O
wild	B:C1520150
-	I:C1520150
type	I:C1520150
mice	I:C1520150
.	O

Moreover	O
,	O
CD177	B:C1824675
deficiency	O
led	O
to	O
compromised	O
intestinal	O
barrier	I:C3821032
and	O
impaired	O
antibacterial	O
immunity	I:C0020964
through	O
decreased	O
production	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
by	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
.	O

Moreover	O
,	O
CD177	O
deficiency	O
led	O
to	O
compromised	O
intestinal	B:C3821032
barrier	I:C3821032
and	O
impaired	O
antibacterial	O
immunity	I:C0020964
through	O
decreased	O
production	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
by	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
.	O

Moreover	O
,	O
CD177	O
deficiency	O
led	O
to	O
compromised	O
intestinal	O
barrier	I:C3821032
and	O
impaired	O
antibacterial	B:C0020964
immunity	I:C0020964
through	O
decreased	O
production	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
by	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
.	O

Moreover	O
,	O
CD177	O
deficiency	O
led	O
to	O
compromised	O
intestinal	O
barrier	I:C3821032
and	O
impaired	O
antibacterial	O
immunity	I:C0020964
through	O
decreased	O
production	O
of	O
IL	B:C0961814
-	I:C0961814
22	I:C0961814
by	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	O
.	O

Moreover	O
,	O
CD177	O
deficiency	O
led	O
to	O
compromised	O
intestinal	O
barrier	I:C3821032
and	O
impaired	O
antibacterial	O
immunity	I:C0020964
through	O
decreased	O
production	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
by	O
CD177	B:C1824675
(	I:C1824675
-)	I:C1824675
neutrophils	O
.	O

Moreover	O
,	O
CD177	O
deficiency	O
led	O
to	O
compromised	O
intestinal	O
barrier	I:C3821032
and	O
impaired	O
antibacterial	O
immunity	I:C0020964
through	O
decreased	O
production	O
of	O
IL	O
-	I:C0961814
22	I:C0961814
by	O
CD177	O
(	I:C1824675
-)	I:C1824675
neutrophils	B:C0027950
.	O

CD177	B:C1824675
(+)	I:C1824675
neutrophils	O
represent	O
functionally	O
activated	O
population	O
and	O
play	O
a	O
protective	O
role	O
in	O
IBD	O
through	O
increased	O
bactericidal	O
activity	I:C0544570
and	O
IL	O
-	I:C0961814
22	I:C0961814
production	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	B:C0027950
represent	O
functionally	O
activated	O
population	O
and	O
play	O
a	O
protective	O
role	O
in	O
IBD	O
through	O
increased	O
bactericidal	O
activity	I:C0544570
and	O
IL	O
-	I:C0961814
22	I:C0961814
production	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
represent	O
functionally	O
activated	O
population	O
and	O
play	O
a	O
protective	O
role	O
in	O
IBD	B:C0021390
through	O
increased	O
bactericidal	O
activity	I:C0544570
and	O
IL	O
-	I:C0961814
22	I:C0961814
production	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
represent	O
functionally	O
activated	O
population	O
and	O
play	O
a	O
protective	O
role	O
in	O
IBD	O
through	O
increased	O
bactericidal	B:C0544570
activity	I:C0544570
and	O
IL	O
-	I:C0961814
22	I:C0961814
production	O
.	O

CD177	O
(+)	I:C1824675
neutrophils	O
represent	O
functionally	O
activated	O
population	O
and	O
play	O
a	O
protective	O
role	O
in	O
IBD	O
through	O
increased	O
bactericidal	O
activity	I:C0544570
and	O
IL	B:C0961814
-	I:C0961814
22	I:C0961814
production	O
.	O

Targeting	O
CD177	B:C1824675
(+	O
)	O
neutrophils	O
may	O
be	O
beneficial	O
for	O
treatment	O
of	O
IBD	O
.	O

Targeting	O
CD177	O
(+	O
)	O
neutrophils	B:C0027950
may	O
be	O
beneficial	O
for	O
treatment	O
of	O
IBD	O
.	O

Targeting	O
CD177	O
(+	O
)	O
neutrophils	O
may	O
be	O
beneficial	O
for	O
treatment	B:C0087111
of	O
IBD	O
.	O

Targeting	O
CD177	O
(+	O
)	O
neutrophils	O
may	O
be	O
beneficial	O
for	O
treatment	O
of	O
IBD	B:C0021390
.	O

